2019 ACCP Virtual Journal Club August | β2‐Adrenergic Receptor Gene Affects the Heart Rate Response of β‐Blockers: Evidence From 3 Clinical Studies - LIVE
Includes a Live Event on 08/28/2019 at 2:00 PM (EDT)
β-Adrenergic Receptor Gene Affects the Heart Rate Response of β-Blockers: Evidence From 3 Clinical Studies - LIVE
ACCP Virtual Journal Club Webinars
Live Session: Wednesday, August 28, 2019 from 2:00-3:00 PM ET
On Demand: August 30, 2019 to August 30, 2022
See Handouts tab for Continuing Education information on CME and CPE credits.
Mohamed Shahin, BPharm, PhD, MBI
Manager, Clinical Pharmacology Lead, Global Product Development, Pfizer Inc
Dr. Shahin is a Clinical Pharmacologist at Pfizer Inc with more than 12 years of experience in the field of Clinical Pharmacology, Pharmacogenomics, Pharmacometabolomics, Systems Biology and Biomedical Informatics. He finished a master's degree in Biomedical Informatics and a PhD in Clinical Pharmaceutical Sciences from the Univ of Florida. Additionally, he completed a fellowship in Pharmacogenomics and Personalized Medicine at the Coll of Pharmacy, Univ of Florida and another fellowship in Informatics at the Univ of Florida Informatics Inst. He has more than 30 research articles published in high impact journals like New England Journal of Medicine, The Lancet, Clinical Pharmacology and Therapeutics, and Hypertension, and has received several awards in recognition of his research work.
Joseph D. Ma, PharmD
Professor, Div of Clinical Pharmacy, Univ of California San Diego, Skaggs School of Pharmacy & Pharmaceutical Sciences
Joseph D. Ma, PharmD, FCP is Professor in the Division of Clinical Pharmacy at the Skaggs School of Pharmacy and Pharmaceutical Sciences, Univ of California San Diego. He is also the faculty director of the Drug Development and Product Management Master’s Program at Univ of California San Diego. He received pharmacy degree from the Univ of California San Francisco and completed a clinical pharmacology fellowship at Bassett Healthcare, Cooperstown, NY. Upon fellowship completion, he was employed at Amgen, Inc in Thousand Oaks, CA. in the Early Development Department.
His research interests are evaluating in vivo drug metabolizing enzyme activity and opioid pharmacokinetic variability. His current clinical practice is the Doris A. Howell Pain and Palliative Care Service at the Univ of California San Diego Moores Cancer Center. Under a collaborative practice agreement he is able to initiate, stop and/or adjust therapy for the management of pain and other physical symptoms associated with cancer and/or chemotherapy.